Cargando…
The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature
Background and objectives: Although it is very uncommon, medication-induced osteonecrosis of the jaw (also known as MRONJ) can have serious consequences. Traditionally, this adverse event has been recognised in patients who were treated with bisphosphonate (BP) drugs. Nevertheless, in recent years,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223182/ https://www.ncbi.nlm.nih.gov/pubmed/37241200 http://dx.doi.org/10.3390/medicina59050968 |
_version_ | 1785049880319754240 |
---|---|
author | Sacco, Roberto Akintola, Oladapo Sacco, Nicola Acocella, Alessandro Calasans-Maia, Monica Diuana Maranzano, Massimo Olate, Sergio |
author_facet | Sacco, Roberto Akintola, Oladapo Sacco, Nicola Acocella, Alessandro Calasans-Maia, Monica Diuana Maranzano, Massimo Olate, Sergio |
author_sort | Sacco, Roberto |
collection | PubMed |
description | Background and objectives: Although it is very uncommon, medication-induced osteonecrosis of the jaw (also known as MRONJ) can have serious consequences. Traditionally, this adverse event has been recognised in patients who were treated with bisphosphonate (BP) drugs. Nevertheless, in recent years, it has been established that individuals having treatment with various types of medications, such as a receptor activator of nuclear factor kappa-Β ligand inhibitor (denosumab) and antiangiogenic agents, have had the same issue. The purpose of this research is to determine if the application of human amniotic membrane (hAM) may be used as a therapy for MRONJ. Material and Methods: A multi-source database (MEDLINE, EMBASE, AMED, and CENTRAL) systematic search was performed. The major objective of this study is to obtain an understanding of the efficacy of hAM when it is employed as a treatment modality for MRONJ. The protocol of this review was registered in the INPLASY register under the number NPLASY202330010. Results: The authors were able to include a total of five studies for the quality analysis, whereas for the quantity evaluation, only four studies were eligible. A total of 91 patients were considered for the investigation. After treatment with human amniotic membrane (hAM), a recurrence of osteonecrosis was observed in n = 6 cases (8.8%). The combined efficacy of surgical therapy and the use of hAM resulted in an overall success rate of 91.2%. Intraoperative complications were only documented in one article, and they were mostly caused by the positioning of the hAM, which led to wound breakdown at the surgical site. Conclusions: Based on the small amount of data and low-quality research included in this study, using human amniotic membranes to treat MRONJ might represent a feasible option. Nevertheless, further studies with a wider patient population are required to understand the long-term impacts. |
format | Online Article Text |
id | pubmed-10223182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102231822023-05-28 The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature Sacco, Roberto Akintola, Oladapo Sacco, Nicola Acocella, Alessandro Calasans-Maia, Monica Diuana Maranzano, Massimo Olate, Sergio Medicina (Kaunas) Review Background and objectives: Although it is very uncommon, medication-induced osteonecrosis of the jaw (also known as MRONJ) can have serious consequences. Traditionally, this adverse event has been recognised in patients who were treated with bisphosphonate (BP) drugs. Nevertheless, in recent years, it has been established that individuals having treatment with various types of medications, such as a receptor activator of nuclear factor kappa-Β ligand inhibitor (denosumab) and antiangiogenic agents, have had the same issue. The purpose of this research is to determine if the application of human amniotic membrane (hAM) may be used as a therapy for MRONJ. Material and Methods: A multi-source database (MEDLINE, EMBASE, AMED, and CENTRAL) systematic search was performed. The major objective of this study is to obtain an understanding of the efficacy of hAM when it is employed as a treatment modality for MRONJ. The protocol of this review was registered in the INPLASY register under the number NPLASY202330010. Results: The authors were able to include a total of five studies for the quality analysis, whereas for the quantity evaluation, only four studies were eligible. A total of 91 patients were considered for the investigation. After treatment with human amniotic membrane (hAM), a recurrence of osteonecrosis was observed in n = 6 cases (8.8%). The combined efficacy of surgical therapy and the use of hAM resulted in an overall success rate of 91.2%. Intraoperative complications were only documented in one article, and they were mostly caused by the positioning of the hAM, which led to wound breakdown at the surgical site. Conclusions: Based on the small amount of data and low-quality research included in this study, using human amniotic membranes to treat MRONJ might represent a feasible option. Nevertheless, further studies with a wider patient population are required to understand the long-term impacts. MDPI 2023-05-17 /pmc/articles/PMC10223182/ /pubmed/37241200 http://dx.doi.org/10.3390/medicina59050968 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sacco, Roberto Akintola, Oladapo Sacco, Nicola Acocella, Alessandro Calasans-Maia, Monica Diuana Maranzano, Massimo Olate, Sergio The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature |
title | The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature |
title_full | The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature |
title_fullStr | The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature |
title_full_unstemmed | The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature |
title_short | The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature |
title_sort | use of human amniotic membrane (ham) as a treatment strategy of medication-related osteonecrosis of the jaw (mronj): a systematic review and meta-analysis of the literature |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223182/ https://www.ncbi.nlm.nih.gov/pubmed/37241200 http://dx.doi.org/10.3390/medicina59050968 |
work_keys_str_mv | AT saccoroberto theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT akintolaoladapo theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT sacconicola theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT acocellaalessandro theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT calasansmaiamonicadiuana theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT maranzanomassimo theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT olatesergio theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT saccoroberto useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT akintolaoladapo useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT sacconicola useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT acocellaalessandro useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT calasansmaiamonicadiuana useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT maranzanomassimo useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature AT olatesergio useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature |